$5.94
0.62[11.65%]
At close: Apr 12
$5.94
0[0.00%]
After Hours: 5:47PM EDT
Aprea Therapeutics
(NASDAQ:APRE)Aprea Therapeutics Stock (NASDAQ:APRE), Earnings Estimates, EPS, and Revenue
Aprea Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
May 13
EPS Estimate
$-0.780
Quarterly Revenue Estimate
–
Annual Revenue
(as of Dec 31)
(as of Dec 31)
–
Analyze the earnings history of Aprea Therapeutics using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 05/13/2024 | PM | APRE | Q1 | -$1.34 | -$0.78 | — | — | $0.00 | — | — | — | Get Alert |
| 03/26/2024 | AM | APRE | Q4 | -$0.92 | -$0.77 | -$0.92 | -19.48% | $0.00 | $110.00K | $14.07K | -87.20% | Get Alert |
| 11/09/2023 | PM | APRE | Q3 | -$2.40 | -$1.16 | -$0.86 | 25.86% | $0.00 | $80.00K | $319.47K | 299.34% | Get Alert |
| 08/10/2023 | AM | APRE | Q2 | -$19.80 | -$1.42 | -$0.87 | 38.73% | $0.00 | — | $249.69K | — | Get Alert |
| 05/15/2023 | PM | APRE | Q1 | -$7.20 | — | -$1.34 | — | $0.00 | — | $0.00 | — | Get Alert |
| 03/30/2023 | PM | APRE | Q4 | -$7.20 | -$2.60 | -$0.92 | 64.62% | $0.00 | — | $0.00 | — | Get Alert |
| 11/09/2022 | PM | APRE | Q3 | -$9.00 | -$5.40 | -$2.40 | 55.56% | $0.00 | — | $0.00 | — | Get Alert |
| 08/12/2022 | PM | APRE | Q2 | -$9.60 | -$7.40 | -$19.80 | -167.57% | $0.00 | — | $0.00 | — | Get Alert |
| 05/16/2022 | AM | APRE | Q1 | -$9.20 | -$7.60 | -$7.20 | 5.26% | $0.00 | — | $0.00 | — | Get Alert |
| 03/15/2022 | PM | APRE | Q4 | -$14.60 | -$8.80 | -$7.20 | 18.18% | $0.00 | — | $0.00 | — | Get Alert |
| 11/08/2021 | PM | APRE | Q3 | -$11.60 | -$8.80 | -$9.00 | -2.27% | $0.00 | — | $0.00 | — | Get Alert |
| 08/12/2021 | PM | APRE | Q2 | -$15.60 | -$9.60 | -$9.60 | 0.00% | $0.00 | — | $0.00 | — | Get Alert |
| 05/06/2021 | AM | APRE | Q1 | -$9.00 | -$9.80 | -$9.20 | 6.12% | $0.00 | — | $0.00 | — | Get Alert |
| 03/16/2021 | PM | APRE | Q4 | -$12.80 | — | -$14.60 | — | $0.00 | — | $0.00 | — | Get Alert |
| 11/05/2020 | PM | APRE | Q3 | -$105.80 | — | -$11.60 | — | $0.00 | — | $0.00 | — | Get Alert |
| 08/11/2020 | AM | APRE | Q2 | -$89.00 | — | -$15.60 | — | — | — | $0.00 | — | Get Alert |
| 05/15/2020 | AM | APRE | Q1 | -$59.40 | — | -$9.00 | — | — | — | $0.00 | — | Get Alert |
| 03/26/2020 | AM | APRE | Q4 | -$81.00 | — | -$12.80 | — | — | — | $0.00 | — | Get Alert |
| 11/14/2019 | PM | APRE | Q3 | — | — | -$105.80 | — | — | — | $0.00 | — | Get Alert |
FAQ
When is Aprea Therapeutics (NASDAQ:APRE) reporting earnings?
Aprea Therapeutics (APRE) is scheduled to report earnings on May 13, 2024. The last reported earnings were for reported on March 26, 2024 for Q4.
What were the latest earnings per share (EPS) for Aprea Therapeutics (NASDAQ:APRE)?
The Actual EPS was $-0.92, which missed the estimate of $-0.77.
What were Aprea Therapeutics’s (NASDAQ:APRE) revenues?
The Actual Revenue was $14.1K, which missed the estimate of $110K.
Browse earnings estimates, EPS, and revenue on all stocks.